Bryan serves clients by developing and implementing creative solutions for complex issues. Specializing in tobacco industry regulatory compliance and enforcement matters, Bryan efficiently assists clients in complying with regulatory obligations and managing risk, consistent with clients' business objectives.
Located in:
Areas of Focus:
Bryan devotes his practice to representing businesses in regulatory compliance matters and disputes involving government agencies, including the Food and Drug Administration (FDA), state attorneys general, and federal and state taxing authorities.
As a member of the firm's Regulatory Investigations, Strategy + Enforcement (RISE) Practice Group and head of the firm's Tobacco + Nicotine practice, Bryan focuses on representing tobacco manufacturers, distributors, retailers, and suppliers in all aspects of their businesses, including tobacco taxation matters, FDA requirements, administrative disputes involving a federal or state governmental entity and commercial agreements. Bryan works with clients in all segments of the tobacco industry, including electronic nicotine delivery systems and other novel products and traditional tobacco products such as cigarettes, cigars, and pipe tobacco.
Bryan has been advising clients regarding compliance with the Family Smoking Prevention and Tobacco Control Act since before the law was passed in 2009. Bryan also advises companies that sell products subject to the FDA's "deeming rule," which gave FDA authority to regulate electronic nicotine delivery systems and other novel products, cigars and pipe tobacco. Bryan assists clients with FDA premarket review requirements, including substantial equivalence (SE) and premarket tobacco applications (PMTA), and has helped companies obtain numerous FDA marketing orders for new tobacco products.
He also advises tobacco companies in connection with Master Settlement Agreement (MSA) compliance issues, including negotiations with state regulators and in litigation. Further, Bryan represents distributors and retailers in connection with state and federal tax compliance and disputes, and has successfully defended manufacturers and distributors in disputes with the Alcohol and Tobacco Tax and Trade Bureau and state revenue departments. Bryan is an accomplished litigator who has served as lead counsel in state and federal courts across the U.S., representing both domestic and international clients.
Bryan frequently presents on tobacco regulatory matters, including at Food and Drug Law Institute and TMA conferences. Follow Bryan's ongoing analysis and commentary on developments in tobacco law at http://www.tobaccolawblog.com/ and https://www.regulatoryoversight.com/.
Speaking Engagements
05.12.24
CannMed 24 Innovation & Investment Summit
Regulatory Oversight
04.23.24
What’s at Stake for the Premium Cigar Industry as DC Circuit Considers FDA Appeal?
Tobacco Law Blog
04.22.24
FDA Launches Legally Marketed Tobacco Products Database
Speaking Engagements
04.22.24
TMA 2024 Annual Meeting
Tobacco Law Blog
04.19.24
Troutman Pepper Tobacco + Nicotine Team to Attend TMA 2024 Annual Meeting and Conference
Regulatory Oversight
04.18.24
Advocacy Organizations Sue FDA Over Delay in Menthol Cigarette Ban